Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Richard M. Neve, Koei Chin, Jane Fridlyand et al. · Cancer Cell · 2006 · 3.2K citations · Full text

Medicine, Cell Biology, Oncology +14

Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

Fabrice André, Bastien Job, Philippe Dessen et al. · Clinical Cancer Research · 2009 · 333 citations

Medicine, Molecular Biology, Molecular Genetics +15

FGFR1 amplification in breast carcinomas: a chromogenic in situhybridisation analysis

Somaia Elsheikh, Andrew R. Green, Maryou B. Lambros et al. · Breast Cancer Research · 2007 · 295 citations · Full text

Medicine, Molecular Biology, Oncology +16

<i>FGFR1</i> Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas

Jorge S. Reis‐Filho, Peter T. Simpson, Nicholas C. Turner et al. · Clinical Cancer Research · 2006 · 269 citations

Medicine, Molecular Biology, Molecular Genetics +17

Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma

Hung Huynh, Van Chanh Ngo, Joseph Fargnoli et al. · Clinical Cancer Research · 2008 · 221 citations · Full text

Medicine, Oncology, Pharmacology +17